These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Reserpine- and tetrabenazine-sensitive transport of (3)H-histamine by the neuronal isoform of the vesicular monoamine transporter. Erickson JD; Eiden LE; Schafer MK; Weihe E J Mol Neurosci; 1995; 6(4):277-87. PubMed ID: 8860238 [TBL] [Abstract][Full Text] [Related]
5. GZ-793A, a lobelane analog, interacts with the vesicular monoamine transporter-2 to inhibit the effect of methamphetamine. Horton DB; Nickell JR; Zheng G; Crooks PA; Dwoskin LP J Neurochem; 2013 Oct; 127(2):177-86. PubMed ID: 23875622 [TBL] [Abstract][Full Text] [Related]
6. Specific derivatization of the vesicle monoamine transporter with novel carrier-free radioiodinated reserpine and tetrabenazine photoaffinity labels. Sievert MK; Hajipour AR; Ruoho AE Anal Biochem; 2007 Aug; 367(1):68-78. PubMed ID: 17559790 [TBL] [Abstract][Full Text] [Related]
7. Identification of conformationally sensitive residues essential for inhibition of vesicular monoamine transport by the noncompetitive inhibitor tetrabenazine. Ugolev Y; Segal T; Yaffe D; Gros Y; Schuldiner S J Biol Chem; 2013 Nov; 288(45):32160-32171. PubMed ID: 24062308 [TBL] [Abstract][Full Text] [Related]
8. Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity. Lohr KM; Stout KA; Dunn AR; Wang M; Salahpour A; Guillot TS; Miller GW ACS Chem Neurosci; 2015 May; 6(5):790-9. PubMed ID: 25746685 [TBL] [Abstract][Full Text] [Related]
9. The Role of Biogenic Amine Transporters in Trace Amine-Associated Receptor 1 Regulation of Methamphetamine-Induced Neurotoxicity. Miner NB; Phillips TJ; Janowsky A J Pharmacol Exp Ther; 2019 Oct; 371(1):36-44. PubMed ID: 31320495 [TBL] [Abstract][Full Text] [Related]
10. Hydrogen ion concentration differentiates effects of methamphetamine and dopamine on transporter-mediated efflux. Wilhelm CJ; Johnson RA; Eshleman AJ; Janowsky A J Neurochem; 2006 Feb; 96(4):1149-59. PubMed ID: 16417578 [TBL] [Abstract][Full Text] [Related]
11. Vesicular monoamine transporter 2 regulates the sensitivity of rat dopaminergic neurons to disturbed cytosolic dopamine levels. Vergo S; Johansen JL; Leist M; Lotharius J Brain Res; 2007 Dec; 1185():18-32. PubMed ID: 18028884 [TBL] [Abstract][Full Text] [Related]
12. Chimeric vesicular monoamine transporters identify structural domains that influence substrate affinity and sensitivity to tetrabenazine. Peter D; Vu T; Edwards RH J Biol Chem; 1996 Feb; 271(6):2979-86. PubMed ID: 8621690 [TBL] [Abstract][Full Text] [Related]
13. Sex differences in dopamine- and vesicular monoamine-transporter functions. Dluzen DE; McDermott JL Ann N Y Acad Sci; 2008 Oct; 1139():140-50. PubMed ID: 18991858 [TBL] [Abstract][Full Text] [Related]
14. Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter. Cozzi NV; Gopalakrishnan A; Anderson LL; Feih JT; Shulgin AT; Daley PF; Ruoho AE J Neural Transm (Vienna); 2009 Dec; 116(12):1591-9. PubMed ID: 19756361 [TBL] [Abstract][Full Text] [Related]
15. A history of ethanol drinking increases locomotor stimulation and blunts enhancement of dendritic dopamine transmission by methamphetamine. Tschumi CW; Daszkowski AW; Sharpe AL; Trzeciak M; Beckstead MJ Addict Biol; 2020 Jul; 25(4):e12763. PubMed ID: 31062485 [TBL] [Abstract][Full Text] [Related]